Search results for: 'nmr tube 5mm pack of 10'

Acetonitrile-d3 with TMS

Ref.	Packaging	I.E.(%)	Price	Add to...
S-0303B-V04A	2 x 0.75 mL	99.96% D	$60.20

1-3 weeks

1-palmitoyl-d31-2-palmitoyl-sn-glycero-3-phosphocholine (16:0-d31-16:0 DPPC)

CD5025P
4 - 8 weeks

• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1-palmitoyl-2-palmitoyl-d31-sn-glycero-3-phosphocholine (16:0-16:0-d31 DPPC)

CD5026P
4 - 8 weeks

• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dihexanoyl-sn-glycero-3-phosphocholine-d40 (6:0 D6PC-d40)

CD5027P
4 - 8 weeks

D6PC, Perdeuterated

1,2-diheptanoyl-sn-glycero-3-phosphocholine-d44 (7:0 D7PC-d44)

CD5028P
4 - 8 weeks

• D7PC, Perdeuterated

1-lauroyl-2-hydroxy-d23-sn-glycero-3-phosphoglycerol (12:0 LLPG-d23)

CD5030P025

$3,800.00

4 - 8 weeks

• LLPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphoglycerol (14:0 LMPG-d27)

CD5031P025

$3,800.00

4 - 8 weeks

• LMPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphoglycerol (16:0 LPPG-d31)

CD5032P025

$3,800.00

4 - 8 weeks

• LPPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-myristoyl-2-hydroxy-d27-sn-glycero-3-phosphocholine (14:0 LMPC-d27)

CD5036P025

$2,860.00

4 - 8 weeks

• LMPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-2-hydroxy-d31-sn-glycero-3-phosphocholine, (16:0 LPPC-d31)

CD5037P025

$2,860.00

4 - 8 weeks

• LPPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

n-tetradecylphosphocholine-d42 (Fos-Choline-14-d42)

CD5041P025

$2,860.00

4 - 8 weeks

• Fos-Choline-14-d42, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphoglycerol (14:0-d27-14:0 DMPG)

CD5042P
4 - 8 weeks

• DMPG, Deuterated on 1' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %

1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphoglycerol (14:0-14:0-d27 DMPG)

CD5052P
4 - 8 weeks

• DMPG, Deuterated on 2' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %

1-myristoyl-d27-2-myristoyl-sn-glycero-3-phosphethanolamine (14:0-d27-14:0 DMPE)

CD5053P
4 - 8 weeks

• DMPE, Deuterated on 1' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-sn-glycero-3-phosphoglycerol-d72 (DMPG-d72)

CD5054P
4 - 8 weeks

• DMPG, Perdeuterated

1,2-dihexanoyl-d22-sn-glycero-3-phosphoethanolamine (6:0 D6PE-d22)

CD5061P025

$2,860.00

4 - 8 weeks

• D6PE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-diheptanoyl-d26-sn-glycero-3-phosphoethanolamine, (7:0 D7PE-d26)

CD5062P025

$2,860.00

4 - 8 weeks

• D7PE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-d54-sn-glycero-3-phosphoethanolamine (14:0 DMPE-d54)

CD5063P025

$2,860.00

4 - 8 weeks

• DMPE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dipalmitoyl-d62-sn-glycero-3-phosphoethanolamine (16:0 DPPE-d62)

CD5064P025

$2,860.00

4 - 8 weeks

• DPPE, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

n-octyl b-D-glucopyranoside-d17 (OG-d17)

CD5065P025

$2,860.00

4 - 8 weeks

• OG, Deuterated on the octyl tail
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

1-myristoyl-2-myristoyl-d27-sn-glycero-3-phosphoethanolamine (14:0-14:0-d27 DMPE)

CD5067P
4 - 8 weeks

• DMPE, Deuterated on 2' acyl chain α-d2
• Deuteration: 98 %
• Chemical purity > 99 %

1,2-dimyristoyl-sn-glycero-3-phosphoethanolamine-d58 (14:0 DMPE-d58)

CD5068P
4 - 8 weeks

• DMPE, Perdeuterated

1-palmitoyl-d31-2-oleoyl-d33-sn-glycero-phosphocholine (16:0-d31-18:1-d33 POPC)

CD5071P025

$7,410.00

4 - 8 weeks

• POPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-d31-2-oleoyl-d33-sn-glycero-phosphoglycerol (16:0-d31-18:1-d33 POPG)

CD5072P025

$8,350.00

4 - 8 weeks

• POPG, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1,2-dioleoyl-d66-sn-glycero-3-phosphocholine (18:1 DOPC-d66)

CD5074P025

$7,410.00

4 - 8 weeks

• DOPC, Deuterated on both acyl chains
• 250 mg
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-d31-2-oleyl-d33-sn-glycero-phosphoserine (16:0-d31-18:1-d33 POPS)

CD5075P
4 - 8 weeks

• POPS, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1,2-dioleoyl-d66-sn-glycero-3-phosphoethanolamine (18:1-d33-18:1-d33 DOPE)

CD5076P
4 - 8 weeks

• DOPE, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1,2-dimyristoyl-d54-sn-glycero-phosphoserine (14:0 DMPS-d54)

CD5077P
4 - 8 weeks

• DMPS, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1,2-dimyristoyl-d54-sn-glycero-3-phosphoserine-d3 (14:0 DMPS-d54,d3)

CD5079P
4 - 8 weeks

• DMPS, Deuterated on both acyl chains and serine
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-d31-2-oleoyl-sn-glycero-phosphoglycerol (16:0-d31-18:1 POPG)

CD5082P
4 - 8 weeks

• DMPC, Deuterated on 1' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1-palmitoyl-2-oleoyl-d33-sn-glycero-phosphoglycerol (16:0-18:1-d33 POPG)

CD5083P
4 - 8 weeks

• DMPC, Deuterated on 2' acyl chain
• Deuteration: 98 %
• Chemical purity > 99 %

1-palmitoyl-2-oleoyl-sn-glycero-phosphoglycerol-d74 (16:0-18:1 POPG-d74)

CD5084P
4 - 8 weeks

POPG, Perdeuterated

1-palmitoyl-d31-2-oleoyl-sn-glycero-phosphocholine (16:0-d31-18:1 POPC)

CD5091P
4 - 8 weeks

• POPC, Deuterated on palmitate chain only
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-2-oleoyl-d33-sn-glycero-phosphocholine (16:0-18:1-d33 POPC)

CD5092P
4 - 8 weeks

• POPC, Deuterated on oleate chain only
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1-palmitoyl-2-oleoyl-sn-glycero-phosphocholine-d82 (16:0-18:1 POPC-d82)

CD5093P
4 - 8 weeks

POPC, Perdeuterated

1,2-dioleoyl-sn-glycero-3-phosphocholine-d76 (18:1 DOPC-d76)

CD5094P
4 - 8 weeks

DOPC, Perdeuterated

1,2-dioleoyl-sn-glycero-3-phosphoglycerol-d76 (18:1 DOPG-d76)

CD5095P
4 - 8 weeks

DOPG, Perdeuterated

1,2-dioleoyl-d66-sn-glycero-3-phosphoglycerol (18:1 DOPG-d66)

CD5096P
4 - 8 weeks

• DOPG, Deuterated on both acyl chains
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

1,2-dioleoyl-d66-sn-glycero-3-phosphoethanolamine-d4 (18:1 DOPE-d70)

CD5098P
4 - 8 weeks

• DOPE, Deuterated on both acyl chains and ethanolamine
• Deuteration: 98 % (except alpha protons that are Deuterated at 50 %)
• Chemical purity > 99 %

Dodecylphosphocholine-d38 (DPC-d38)

CD600P025
4 - 8 weeks

• DPC, Perdeuterated
• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

2-Ketobutyric Acid-4-13C, 4-d1

CCD1400P1
2 - 4 weeks

• Sodium Salt Hydrate
• 99% ¹³C, 97% D
• Contains 5-10% CD₂H
• 1 g

13C, 15N GB1 in 1.3 mm Bruker rotor

CCN100321P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D Ubiquitin in 1.3 mm Bruker rotor

CCN100621P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in 1.3 mm Bruker rotor

CCND100321P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Ubiquitin in 1.3 mm Bruker rotor

CCND100621P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N SH3 in 1.3mm Bruker rotor

CCN100521P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D SH3 in 1.3mm Bruker rotor

CCND100521P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N GB1 in 3.2 mm Bruker rotor

CCN100323P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D Ubiquitin in 3.2 mm Bruker rotor

CCN100623P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in 3.2 mm Bruker rotor

CCND100323P
3 - 6 weeks

• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N Ubiquitin in 3.2 mm Bruker rotor

CCND100623P
3 - 6 weeks

• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N SH3 in 3.2mm Bruker rotor

CCN100523P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D SH3 in 3.2mm Bruker rotor

CCND100523P
3 - 6 weeks

• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N Calbindin in Solution

CCN10014P20
3 - 6 weeks

• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N Calbindin in Solution

CCN10014P5
3 - 6 weeks

• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline GB1

CCN10033P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline GB1

CCN10033P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N GB1 in Solution

CCN10034P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N GB1 in Solution

CCN10034P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N MBP in Solution

CCN10044P20
3 - 6 weeks

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N

13C, 15N MBP in Solution

CCN10044P5
3 - 6 weeks

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N

13C, 15N SH3 in Solution

CCN10054P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N SH3 in Solution

CCN10054P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6k Da
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline Ubiquitin

CCN10063P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline Ubiquitin

CCN10063P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C 15N Ubiquitin in Solution

CCN10064P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Ubiquitin in Solution

CCN10064P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D Calbindin in Solution

CCND10014P20
3 - 6 weeks

• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Calbindin in Solution

CCND10014P5
3 - 6 weeks

• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline GB1

CCND10033P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline GB1

CCND10033P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in Solution

CCND10034P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D GB1 in Solution

CCND10034P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D MBP in Solution

CCND10044P20
3 - 6 weeks

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D MBP in Solution

CCND10044P5
3 - 6 weeks

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Microcrystalline Ubiquitin

CCND10063P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D Ubiquitin in Solution

CCND10064P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹³C, ¹⁵N, D

15N Calbindin in Solution

CN10014P20
3 - 6 weeks

• 20 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹³C, ¹⁵N, D

15N Calbindin in Solution

CN10014P5
3 - 6 weeks

• 5 mg
• Calbindin-d9k: Vitamin D-dependent Calcium-Binding protein
• Calcium loaded
• Protein size: 8.5 kDa
• Labeling: ¹⁵N

15N Microcrystalline GB1

CN10033P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹⁵N

15N Microcrystalline GB1

CN10033P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• Size: 6.2 kDa
• Labeling: ¹⁵N

15N GB1 in Solution

CN10034P20
3 - 6 weeks

• 20 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹⁵N

15N GB1 in Solution

CN10034P5
3 - 6 weeks

• 5 mg
• B-1 Immunoglobulin G Binding Domain (GB1)
• Residues 303-357 of the protein G, with T303Q mutation
• 6.2 kDa
• Labeling: ¹⁵N

15N MBP in Solution

CN10044P20
3 - 6 weeks

• 20 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹⁵N

15N MBP in Solution

CN10044P5
3 - 6 weeks

• 5 mg
• Maltose Binding Protein (Recombinant MBP)
• Recombinant MBP
• Size: 40.3 kDa
• Residues: 27-392 with T28I mutation
• Labeling: ¹⁵N

15N SH3 in Solution

CN10054P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N SH3 in Solution

CN10054P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N Microcrystalline Ubiquitin

CN10063P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Microcrystalline Ubiquitin

CN10063P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Ubiquitin in Solution

CN10064P20
3 - 6 weeks

• 20 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

15N Ubiquitin in Solution

CN10064P5
3 - 6 weeks

• 5 mg
• Full length Ubiquitin (Residue 1-76)
• Protein size: 6.8 kDa
• Labeling: ¹⁵N

13C, 15N Microcrystalline SH3

CCN10053P20
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N Microcrystalline SH3

CCN10053P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N

13C, 15N, D SH3 in Solution

CCND10054P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹³C, ¹⁵N, D

13C, 15N, D SH3 in Solution

CCND10054P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 k Da
• Labeling: ¹³C, ¹⁵N, D

15N Microcrystalline SH3

CN10053P20
3 - 6 weeks

• 20 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

15N Microcrystalline SH3

CN10053P5
3 - 6 weeks

• 5 mg
• SRC Homology 3 domain (SH3)
• Number of residues: 62
• Protein size: 5.6 kDa
• Labeling: ¹⁵N

n-dodecyl b-D-maltopyranoside-d25 (DDM-d25)

CD5066P025

$2,860.00

4 - 8 weeks

• 250 mg
• Deuteration: 98 %
• Chemical purity > 99 %

Search results for: 'nmr tube 5mm pack of 10'

Shop

Experience

Useful Links

Corporate